Skip to main content
Top
Published in: International Journal of Mental Health and Addiction 1/2020

01-02-2020 | Original Article

A Narrative Review of Pharmacotherapy Treatment for Opioid Addiction and Application in a Community-Based Model in Victoria, Australia

Authors: Tejaswini Patil Vishwanath, Penelope Cash, Wendy Penney, Robyn Cant

Published in: International Journal of Mental Health and Addiction | Issue 1/2020

Login to get access

Abstract

To review the literature regarding the value and consumer focus of research on opioid replacement therapy (ORT) programs, relevant to the Australian rural context and community pharmacy. We conducted a narrative review of literature published between 1995 and 2015, searching EBSCOhost, PubMed and Google Scholar. Three authors collaborated to screen and synthesise studies. Effectiveness, cost affordability, diversion and retention benefits were reported from pharmacological or prescribers’ or dispensers’ standpoint. Research was fragmented and evaluated contributions of these individual types of stakeholders with less discussion of consumers, or consumers’ everyday experiences of ORT. No studies took into account consumers’ psychosocial aspects or power discourses. We found ORT as a beneficial treatment for opioid dependence is well researched, although overall Australian program evaluation was lacking. A gap within ORT literature should be addressed by making consumer experiences central in designs for future research and for program evaluation.
Literature
go back to reference Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329.CrossRefPubMed Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329.CrossRefPubMed
go back to reference Burns, L., Randall, D., & Hall, W. D. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction, 104, 1363–1372.CrossRefPubMed Burns, L., Randall, D., & Hall, W. D. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction, 104, 1363–1372.CrossRefPubMed
go back to reference Centers for Disease Control and Prevention. 1999. Framework for program evaluation in public health. MMWR,;48: RR-11. Centers for Disease Control and Prevention. 1999. Framework for program evaluation in public health. MMWR,;48: RR-11.
go back to reference Chalmers, J., & Ritter, A. (2012). Subsidising patient dispensing fees: The cost of injecting equity into the opioid pharmacotherapy maintenance system. Drug and Alcohol Review, 31(7), 911–917.CrossRefPubMed Chalmers, J., & Ritter, A. (2012). Subsidising patient dispensing fees: The cost of injecting equity into the opioid pharmacotherapy maintenance system. Drug and Alcohol Review, 31(7), 911–917.CrossRefPubMed
go back to reference Chalmers, J., Ritter, A., Heffernan, M., & McDonnell, G. (2009). Modelling pharmacotherapy maintenance in Australia. Research Paper no. 19, Australian National Council on Drugs. Canberra. Chalmers, J., Ritter, A., Heffernan, M., & McDonnell, G. (2009). Modelling pharmacotherapy maintenance in Australia. Research Paper no. 19, Australian National Council on Drugs. Canberra.
go back to reference Crawford, S. (2013). Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic. The International Journal on Drug Policy, 24, e14–e17.CrossRefPubMed Crawford, S. (2013). Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic. The International Journal on Drug Policy, 24, e14–e17.CrossRefPubMed
go back to reference Cronin, P., Ryan, F., & Coughlan, M. (2008). Undertaking a literature review: a step-by-step approach. British Journal of Nursing, 17(1), 38–43.CrossRefPubMed Cronin, P., Ryan, F., & Coughlan, M. (2008). Undertaking a literature review: a step-by-step approach. British Journal of Nursing, 17(1), 38–43.CrossRefPubMed
go back to reference Darke. S., Ross, J., & Hall, W., (1996). Overdose among heroin users in Sydney, Australia II: responses to overdoses. Addiction, 91, 413–17. Darke. S., Ross, J., & Hall, W., (1996). Overdose among heroin users in Sydney, Australia II: responses to overdoses. Addiction, 91, 413–17.
go back to reference Department of Health. (2016). Policy for maintenance pharmacotherapy for opioid dependence. Melbourne: State of Victoria, Department of Health. Department of Health. (2016). Policy for maintenance pharmacotherapy for opioid dependence. Melbourne: State of Victoria, Department of Health.
go back to reference Digiusto, E., Shakeshaft, A. P., Ritter, A., Mattick, R. P., White, J., Lintzeris, N., et al. (2006). Effects of pharmacotherapies for opioid dependence on participants’ criminal behaviour and expenditure on illicit drugs: an Australian national evaluation (NEPOD). Australian and New Zealand Journal of Criminology, 39(2), 171–189.CrossRef Digiusto, E., Shakeshaft, A. P., Ritter, A., Mattick, R. P., White, J., Lintzeris, N., et al. (2006). Effects of pharmacotherapies for opioid dependence on participants’ criminal behaviour and expenditure on illicit drugs: an Australian national evaluation (NEPOD). Australian and New Zealand Journal of Criminology, 39(2), 171–189.CrossRef
go back to reference Doran, C. M., Shanahan, M., Digiusto, E., O’Brien, S., & Mattick, R. P. (2006). Cost-effectiveness analysis of maintenance agonist treatments in the NEPOD. Expert Review of Pharmacoeconomics & Outcomes Research, 6(4), 437–446.CrossRef Doran, C. M., Shanahan, M., Digiusto, E., O’Brien, S., & Mattick, R. P. (2006). Cost-effectiveness analysis of maintenance agonist treatments in the NEPOD. Expert Review of Pharmacoeconomics & Outcomes Research, 6(4), 437–446.CrossRef
go back to reference Fraser, S. (2006). The chronotope of the queue: methadone maintenance treatment and the production of time, space and subjects. The International Journal on Drug Policy, 17, 192–202.CrossRef Fraser, S. (2006). The chronotope of the queue: methadone maintenance treatment and the production of time, space and subjects. The International Journal on Drug Policy, 17, 192–202.CrossRef
go back to reference Gisev, N., Shanahan, M., Weatherburn, D. J., Mattick, R. P., Larney, S., Burns, L., & Degenhardt, L. (2015). A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence. Addiction, 110(12), 1975–1984. https://doi.org/10.1111/add.13073.CrossRefPubMed Gisev, N., Shanahan, M., Weatherburn, D. J., Mattick, R. P., Larney, S., Burns, L., & Degenhardt, L. (2015). A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence. Addiction, 110(12), 1975–1984. https://​doi.​org/​10.​1111/​add.​13073.CrossRefPubMed
go back to reference Holliday, S., Magin, P., Oldmeadow, C., Attia, J., Dunbabin, J., Henry, J., et al. (2013). An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy. Drug and Alcohol Review, 32(5), 495–503.PubMed Holliday, S., Magin, P., Oldmeadow, C., Attia, J., Dunbabin, J., Henry, J., et al. (2013). An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy. Drug and Alcohol Review, 32(5), 495–503.PubMed
go back to reference Horyniak, D., Dietze, P., Larance, B., Winstock, A., & Degenhardt, L. (2011). The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia. The International Journal on Drug Policy, 22(2), 167–171.CrossRefPubMed Horyniak, D., Dietze, P., Larance, B., Winstock, A., & Degenhardt, L. (2011). The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia. The International Journal on Drug Policy, 22(2), 167–171.CrossRefPubMed
go back to reference King, T., Ritter, A., & Berends, L. (2010). Victorian pharmacotherapy review. Sydney: National Drug and Alcohol Research Centre. King, T., Ritter, A., & Berends, L. (2010). Victorian pharmacotherapy review. Sydney: National Drug and Alcohol Research Centre.
go back to reference Lawrinson, P., Lawrinson, P., Roche, A., Lawrinson, P., Roche, A., Terao, H., et al. (2008). Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists. Drug and Alcohol Review, 27(1), 47–53.CrossRefPubMed Lawrinson, P., Lawrinson, P., Roche, A., Lawrinson, P., Roche, A., Terao, H., et al. (2008). Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists. Drug and Alcohol Review, 27(1), 47–53.CrossRefPubMed
go back to reference Le, P.-P., & Hotham, E. D. (2008). South Australian rural community pharmacists and the provision of methadone, buprenorphine and injecting equipment. International Journal of Pharmacy Practice, 16, 149–154.CrossRef Le, P.-P., & Hotham, E. D. (2008). South Australian rural community pharmacists and the provision of methadone, buprenorphine and injecting equipment. International Journal of Pharmacy Practice, 16, 149–154.CrossRef
go back to reference Lea, T., Sheridan, J., & Winstock, A. (2008). Consumer satisfaction with opioid treatment services at community pharmacies in Australia. Pharmacy World & Science, 30, 940–946.CrossRef Lea, T., Sheridan, J., & Winstock, A. (2008). Consumer satisfaction with opioid treatment services at community pharmacies in Australia. Pharmacy World & Science, 30, 940–946.CrossRef
go back to reference Mattick, R. P., Digiusto, E., Doran, C., O’Brien, S., Shanahan, M., Kimber, J., et al. (2004). National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): report of results and recommendations. Canberra: Department of Health and Ageing. Mattick, R. P., Digiusto, E., Doran, C., O’Brien, S., Shanahan, M., Kimber, J., et al. (2004). National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): report of results and recommendations. Canberra: Department of Health and Ageing.
go back to reference Muhleisen, P., Clark, N., Teo, A., & Brogan, D. (2005). Opioid substitution therapy considering the costs to consumers. Of Substance: The National Magazine on Alcohol, Tobacco and Other Drugs, 3, 14. Muhleisen, P., Clark, N., Teo, A., & Brogan, D. (2005). Opioid substitution therapy considering the costs to consumers. Of Substance: The National Magazine on Alcohol, Tobacco and Other Drugs, 3, 14.
go back to reference Peterson, G. M., Wu, M. S. H., & Bergin, J. K. (1999). Pharmacists’ attitudes towards dispensing errors: their causes and prevention. Journal of Clinical Pharmacy and Therapeutics, 24, 57–71.CrossRefPubMed Peterson, G. M., Wu, M. S. H., & Bergin, J. K. (1999). Pharmacists’ attitudes towards dispensing errors: their causes and prevention. Journal of Clinical Pharmacy and Therapeutics, 24, 57–71.CrossRefPubMed
go back to reference Ritter, A., & Chalmers, J., (2009). Polygon: the many sides to the Australian opioid pharmacotherapy maintenance system, Research Paper no. 18, Australian National Council on Drugs, Canberra. Ritter, A., & Chalmers, J., (2009). Polygon: the many sides to the Australian opioid pharmacotherapy maintenance system, Research Paper no. 18, Australian National Council on Drugs, Canberra.
go back to reference Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., et al. (2005). The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review, 24(5), 411–418.CrossRefPubMed Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., et al. (2005). The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review, 24(5), 411–418.CrossRefPubMed
go back to reference Rowe, J. (2008). A Raw Deal. Melbourne: RMIT University and the Salvation Army. Rowe, J. (2008). A Raw Deal. Melbourne: RMIT University and the Salvation Army.
go back to reference Shepherd, A., Perrella, B., & Hattingh, H. L. (2014). The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study. Substance Abuse Treatment, Prevention, and Policy, 9(1), 32.CrossRefPubMedPubMedCentral Shepherd, A., Perrella, B., & Hattingh, H. L. (2014). The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study. Substance Abuse Treatment, Prevention, and Policy, 9(1), 32.CrossRefPubMedPubMedCentral
go back to reference Treloar, C., Rance, J., Madden, A., & Liebelt, L. (2011). Evaluation of consumer participation demonstration projects in five Australian drug user treatment facilities: the impact of individual versus organizational stability in determining project progress. Substance Use & Misuse, 46(8), 969–979.CrossRef Treloar, C., Rance, J., Madden, A., & Liebelt, L. (2011). Evaluation of consumer participation demonstration projects in five Australian drug user treatment facilities: the impact of individual versus organizational stability in determining project progress. Substance Use & Misuse, 46(8), 969–979.CrossRef
go back to reference Ward, J., Mattick, R., & Hall, W. (1998). Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic. Ward, J., Mattick, R., & Hall, W. (1998). Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic.
go back to reference Ward, J., Hall, W., & Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence. Lancet, 353(9148), 221–226.CrossRefPubMed Ward, J., Hall, W., & Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence. Lancet, 353(9148), 221–226.CrossRefPubMed
go back to reference Welfare AIoHa. (2015) National opioid pharmacotherapy statistics 2014. Bulletin 128. Welfare AIoHa. (2015) National opioid pharmacotherapy statistics 2014. Bulletin 128.
go back to reference Winstock, A. R., Lea, T., & Sheridan, J. (2008). Patients’ help-seeking behaviours for health problems associated with methadone and buprenorphine treatment. Drug and Alcohol Review, 27, 393–397.CrossRefPubMed Winstock, A. R., Lea, T., & Sheridan, J. (2008). Patients’ help-seeking behaviours for health problems associated with methadone and buprenorphine treatment. Drug and Alcohol Review, 27, 393–397.CrossRefPubMed
go back to reference Winstock, A. R., Lea, T., & Sheridan, J. (2010). Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia. Addiction, 105, 335–342.CrossRefPubMed Winstock, A. R., Lea, T., & Sheridan, J. (2010). Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia. Addiction, 105, 335–342.CrossRefPubMed
Metadata
Title
A Narrative Review of Pharmacotherapy Treatment for Opioid Addiction and Application in a Community-Based Model in Victoria, Australia
Authors
Tejaswini Patil Vishwanath
Penelope Cash
Wendy Penney
Robyn Cant
Publication date
01-02-2020
Publisher
Springer US
Published in
International Journal of Mental Health and Addiction / Issue 1/2020
Print ISSN: 1557-1874
Electronic ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-018-9936-2

Other articles of this Issue 1/2020

International Journal of Mental Health and Addiction 1/2020 Go to the issue